Introduction
Chemi cal selectivity is highly desirable in conjugation of fluorophores to biomolecules for spectroscopic applications or covalent attachment of biomolecules to surfaces. [1] [2] [3] [4] Typical conjugation methods include the incorporation of natural and unnatural amino acids as attachment sites within the protein of interest. [5] [6] [7] With the advances in site-directed mutagenesis, a typical technique is to mutate an amino acid site to a cysteine for conjugation of thiol-reactive fluorophores. [8] [9] [10] [11] A number of thiol-reactive reagents are available for cysteine conjugations such as iodoacetamides, iodoacetyl esters, maleimides, and bromoacetamides. 12 For attaching a single dye to a protein with no other available cysteines, this technique can be both efficient and highly specific. However, for controlled attachment of two different dyes at two separate cysteines, which is desired for constructing a glucose-responsive biosensor based on fluorescence resonance energy transfer (FRET), this strategy presents challenges.
Conceivably, if a binding protein undergoes a large conformational change between the bound and unbound states, then some sites in or near the binding pocket may be inaccessible in the bound state while others outside the binding pocket would be accessible, as illustrated in Figure 1 . In such a case, a surface residue could be labeled with one dye while the protein was bound to its ligand (i.e., glucose in this example). Removal of the ligand would then expose the site in or near the binding pocket for attachment of a second dye. We describe this selective approach as the "ligand protection" technique.
Some related examples have been reported for exploiting differential cysteine reactivity in oat phytochrome A, 15 for reversible protection of cysteines in a zinc finger by disulfide bond formation, 16 and by denaturing and refolding a protein to selectively label blocked cysteine sites. 17 This last method requires that refolding of the doubly labeled protein is both efficient and unhindered by the dyes themselves.
Here, we describe how chemical selectivity for one of two cysteines has been successfully manipulated with the ligand protection technique in a periplasmic binding protein (PBP) that changes confirmation upon binding of ligand. This selectivity is performed without the need to denature and refold the protein. Periplasmic binding proteins generally consist of two globular domains attached by a hinge region. The ligand of interest binds between the two domains, leading the protein to close the hinge about the ligand, bringing the two domains closer. [18] [19] [20] This model is often referred to as the Venus flytrap of proteins. 21 In particular, we describe the application of the ligand protection technique to the glucose/galactose binding protein (GGBP) from Escherichia coli, which binds glucose and galactose with high selectivity over other saccharides. 13, 22 The potential of GGBP for in vivo blood glucose monitoring has been frequently suggested. 10, 11, 23, 24 A prototype continuous glucose fiber optic sensor based on GGBP was evaluated in preclinical studies, 25 and the sensor has further demonstrated competitive accuracy in a human feasibility study. 26 The GGBP in the prototype sensor was labeled with a single environment-sensitive fluorophore, acrylodan. In this study, we describe an alternate design for a GGBP glucose sensor that pairs the environmentsensitive fluorophore nitrobenzoxadiazole (NBD) with Texas Red (TR) as the FRET donor and acceptor, respectively. This FRET sensor was constructed using the ligand protection strategy, which we propose to have utility for many other protein-labeling applications.
Methods

Materials
The thiol-reactive dyes N,N'-dimethyl-N-(iodoacetyl)-N'-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)ethylenediamine Figure 1 . Glucose/galactose binding protein is known to exhibit a hinge-twist conformational change upon binding of ligand. 13, 14 Here we suggest that, when two cysteine sites (SH) are available on the protein, one may be protected by the presence of ligand, allowing the remaining cysteine site to be selectively labeled.
(IANBD) amide, TR C2 maleimide, and TR C5 bromoacetamide were purchased from Invitrogen (Eugene, OR). Glucose was obtained from Sigma-Aldrich (St. Louis, MO); phosphate buffered saline (PBS; 10 mM phosphate buffer, 137 mM NaCl, 2.7 mM KCl, pH 7.4) was prepared from tablets (Sigma-Aldrich) or 10X solution (EM Sciences, Hatfield, PA). Nap TM columns were obtained from GE Health Care Life Sciences (Piscataway, NJ), and YM-100 micron filters were products of Millipore (Billerica, MA).
Site-Directed Mutagenesis and Protein Purification
The GGBP mutations were prepared using the QuikChange method (Stratagene, La Jolla, CA) as previously described. 27 The GGBP constructs were confirmed by deoxyribonucleic acid sequencing at the University of North Carolina at Chapel Hill sequencing facility. The protein expression vector pQE-70 and nickel-nitrilotriacetic acid resin for protein purification were purchased from Qiagen (Valencia, CA).
Ligand Protection: Single Cysteine Mutant (Controls)
The GGBP mutant (either A213C GGBP or E149C GGBP, 8 nmol) was incubated with 20 nmol (2.5X) dithiothreitol (DTT) for 15-30 min. The GGBP/DTT solution was evenly divided into two solutions and then further incubated for 30 min with a 1:10 V:V addition of 1 M glucose in PBS (ligand protected sample) or PBS (negative control). Freshly prepared 12 mM IANBD in dimethyl sulfoxide was added to each solution with a final concentration of 5X molar excess; the solution was incubated in the dark for 30 min. Next, the majority of the free dye/glucose was removed by gel filtration using Nap columns. The absorbance spectra of the samples were measured using a Cary 50 Bio ultraviolet-visible spectrophotometer (Varian Inc., Palo Alto, CA).
Ligand Protection: E149C/A213C/L238S
For the double cysteine mutant E149C/A213C/L238S (CCS), the glucose positive sample was carried through the described procedure for the single cysteine mutant with the following differences: the cysteine/DTT/IANBD molar ratios were 1/5/2.5 and the control (no glucose) solution was 1/3 of the sample preparation. After removal of both glucose and free IANBD by gel filtration and extensive dialysis at 4 °C in the dark, the NBD-CCS was incubated with 5X DTT for 10-15 min. Next, 15-20X TR (C2 maleimide or C5 bromoacetamide) was added and reacted for 2-4 h at room temperature. In some cases, the reaction was further incubated overnight at 4 °C in the dark. The free TR dye was removed through extensive dialysis as described earlier. Filtration was performed using YM-100 µm filters according to the manufacturer's instructions to remove aggregated protein; the absorbance spectrum of the final product was measured.
Absorbance
The dye/protein ratio was calculated spectroscopically using the following extinction coefficients: GGBP ε 280 = 50,167 M -1 cm -1 estimated from 1.5 optical density = 1 mg/ml; NBD ε 500 = 25,000 M -1 cm -1
; and TR ε 560 = 115,000 M -1 cm -1
(for both C2 and C5). The correction factors for NBD and TR were 0.18 and 0.19, respectively, at A 280 ; the correction factor for TR was 0.05 at A 500 .
Fluorescence Measurements
Protein solutions (1 µM) were combined with varying amounts of glucose in PBS, incubated at room temperature for a minimum of 30 min, and then measured on a QM-4/2003 SE fluorometer (Photon Technologies Inc., Birmingham, NJ). Fluorometer conditions include slit widths of 4/4 nm, excitation wavelength 475 nm, emission wavelength range 500-700 nm, and room temperature measurement.
Fluorescence Intensity Response
The NBD fluorescence response to the glucose signal was defined as QF, where QF is the fluorescence at high (typically 100 mM) glucose levels divided by the fluorescence in the absence of glucose. For the QF measurement, the shape of the fluorescent spectrum does not undergo a change.
Determination of K apparent
The glucose titration for NBD-TR CCS was fit to the following equation:
where x is the glucose concentration and R is the ratio of the intensity; R = F(540 nm) / F(610 nm). The free parameters are R 0 , R const , and K apparent , where R inf is F 0 + K apparent × R const , R 0 is the theoretical R value at zero glucose, and R inf is the theoretical R value at infinite glucose concentrations.
Molecular Modeling
The molecular modeling was performed using Sybyl (Tripos, St. Louis, MO). The closed conformation of GGBP bound to glucose was generated from the Protein Data Bank 28 structure 2GBP. The open conformation of GGBP was created as a model based on the open form crystal structure of ribose binding protein 2DRI as a template. 29 Models of the open and closed forms of CCS with NBD conjugated to E149C and TR C2 maleimide or TR C5 bromoacetamide conjugated to A213C were analyzed using genetic algorithm conformational searches. The number of rotatable bonds assigned in the linker of each dye was 7 for NBD, 6 for TR C2, and 10 for TR C5. Amide bonds in the linkers were not treated as rotatable. The population size was 500 with 10,000 generations in a run. The torsional angle duplicate window was set to 10, and the maximum number of hits within a 20 kcal/mol energy window was set to 20. Otherwise, default settings in the genetic algorithm search were used.
Results
Dye Labeling of Single Mutants
The single cysteine mutants A213C GGBP and E149C GGBP were labeled with IANBD ( Figure 2 ) in the presence and absence of glucose to determine the accessibility of these sites to the dye in the bound and unbound states, respectively. Calculated dye/protein ratios are reported in Table 1 . The presence of glucose reduced the amount of A213C labeled with NBD by 70%. Covalent attachment of NBD to the E149C site, on the other hand, was unaffected by the presence of glucose.
Dye Labeling of Double Cysteine Mutants
The double cysteine mutant CCS GGBP was labeled with IANBD in the presence and absence of glucose. The dye/ protein ratios in Table 1 indicate that two NBD molecules were attached to the double cysteine mutant in the absence of glucose. For preparation of the protein labeled with two different dyes, CCS GGBP was first labeled with IANBD in the presence of glucose. Following dialysis of the protein to remove glucose, the resulting NBD-CCS was then labeled with either TR C5 bromoacetamide or TR C2 maleimide. Nitrobenzoxadiazole and TR have been previously used as energy transfer pairs. 30 The NBD/ TR/protein ratio was calculated to be 1.4/0.4/1 for both NBD-TR constructs.
A comparison of the NBD absorption maxima (Figure 3 ) indicated a significant difference in NBD absorbance for the double mutant labeled with two NBD dyes when compared with E149C-NBD GGBP and A213C-NBD GGBP, as well as with the two NBD-TR-CCS GGBP conjugates (discussed later).
Fluorescence Response to Glucose
The fluorescence responses (QF) of NBD-labeled GGBPs are shown in Table 1 . These responses were changes in fluorescence intensity, but not spectral shape, and ranged from 1.7 to 11.7. The more complex responses of the NBD-TR CCS constructs are shown in Figure 4 . The NBD-TR constructs (NBD-TR CCS) with either the C2 maleimide or the C5 bromoacetamide showed considerable fluorescence energy resonance transfer in the absence of glucose, in that the donor molecule (NBD) has low fluorescence and the acceptor molecule (TR) has high fluorescence. Upon titration with glucose, the fluorescence signals of both donor and acceptor molecules increased for both constructs. The increase in the acceptor fluorescence for NBD-TR C2 maleimide CCS (NBD-TR C2 CCS) was less than that of the C5 bromoacetamide construct (NBD-TR C5 CCS; 1.4X increase compared with 2.8X increase). Using the ratio of F(540 nm)/F(610 nm), titration of constructs against glucose ( Figure 5 ) afforded ratio changes of 3x for NBD-TR C2 CCS and 2x for NBD-TR C5 CCS. The K apparent values were 6.2 mM for NBD-TR C2 CCS and 1.7 mM for NBD-TR C5 CCS, which are within the human physiological glucose range (1-30 mM).
Molecular Modeling
Genetic algorithm conformational searches on the closed form models of NBD-TR C2 CCS and NBD-TR C5 CCS returned two conformations for each protein. The relative energies for the C2 protein conformations were 462.4 and 
Discussion
We have prepared NBD-TR CCS constructs, whereby two different cysteine-reactive dyes are attached to the same protein, GGBP, using a process called ligand protection. Texas Red was conjugated to GGBP through reaction with either a C2 maleimide or a C5 bromoacetamide linker as shown in Figure 2 . Most likely, NBD was predominantly attached at E149C and TR at A213C (see later discussion). When the NBD fluorophore was excited in these constructs, energy transfer was observed from NBD to TR. The signal for TR in the C2 construct was higher in the absence of glucose than the signal for TR in the C5 construct. However, the signal from TR in the C5 construct had a larger dynamic range than TR in the C2 construct when bound to glucose. When fully bound to glucose, intensities in the TR signal were similar in magnitude for the two constructs.
The labeling experiments with the single mutation controls indicated that the A213C site is less accessible in the presence of glucose, while the E149C site is unaffected under similar conditions, based on the dye/protein ratios obtained in the presence and absence of glucose. Examination of the X-ray crystal structure of the closed form and our open form model agreed with these results. In the closed form, A213C is located in a cleft. Access to the cysteine is restricted by the side chains of M216 and T185 from the C-terminal domain (in the same domain as A213C) and by N15 on the N-terminal domain. In the model of the open conformation, the restriction from the N15 side chain is removed, thereby allowing the dye to react more readily with the cysteine thiol. E149C, on the other hand, is solvent exposed in the open and the closed forms, and no significant differences are observed for this site in the two conformations.
The results for the labeling of the double cysteine mutant CCS with IANBD in the presence of glucose indicated that the accessibility of the E149C and A213C sites to the fluorophore was essentially the same as in the respective single cysteine mutants ( Table 1) . The fluorescence response (QF) for the labeled CCS protein upon glucose binding (QF = 8.2) was nearly the same as the fluorescence response for NBD-E149C GGBP (QF = 8.0) and much greater than the response for NBD-A213C GGBP (QF = 1.7). This indirect evidence from the dye/protein ratios and fluorescence response suggests that, in the double cysteine mutant, NBD is attached preferentially to the E149C site, although it is possible some smaller fraction of the dye may attach to A213C as well.
The mechanism for the two dual-labeled NBD-TR CCS proteins appears to result primarily from the large change in fluorescence intensity upon glucose binding of the environment-sensitive donor fluorophore NBD at the E149C site 11 as well as a modest contribution from distancedependent FRET between NBD and TR. The absorbance spectra of NBD for both NBD-TR C2 CCS and NBD-TR C5 CCS (Figure 3) do not indicate that any ground state perturbation of NBD is occurring, unlike the case of doubly labeled 2NBD CCS, in which a significant blue shift is observed. A slight increase in the TR shoulder region (~550 nm), however, was observed for NBD-TR C2 CCS as compared with NBD-TR C5 CCS.
The conformational searches measured by molecular modeling provide a possible explanation for the observed energy transfer. The conformational flexibility of the C2 maleimide was expected to be reduced compared with the C5 bromoacetamide since the C2 maleimide has three less atoms in the linker chain between the dye and the thiol of cysteine. The maleimide ring, which converts to a succinimide following attachment, also would reduce the conformation motion of the dye. As seen in Figure 6 , the open form conformers of the dyes supported this expectation. The TR C2 dye showed almost no significant change in the orientation of the dye among the 20 conformers ( Figure 6A ). Texas Red C5 dye, however, produced a number of unique conformations for the dye as a result of the greater flexibility in the linear linker ( Figure 6C) . Thus it is possible that the greater rigidity of TR in the C2 construct provides a more efficient transfer of energy in the absence of glucose compared with TR in the C5 construct. In the closed forms, the TR dye in both constructs was greatly restricted in motion, and only two conformers were obtained for each construct. The location of TR in these conformations was similar for both NBD-TR C2 CCS ( Figure 6B ) and NBD-TR C5 CCS ( Figure 6D ) with respect to NBD and the protein surface. Consequently, the energy transfer between NBD and TR in either protein is approximately the same, which would account for the similarity in magnitude of the TR signal in both proteins.
The contributions of the respective mutations on glucose binding affinity were mostly anticipated from prior studies for labeling GGBP with NBD. 11, 27 Labeling E149C with NBD shows little change from the wild-type GGBP glucose affinity (0.2 µM). Adding L238S to produce E149C/L238S shifts the glucose affinity to 0.080 mM. Labeling of A213C GGBP with NBD gave an affinity of 0.124 mM. The triple mutant E149C/A213S/L238S had a dissociation constant of 0.5 mM as measured by surface plasmon resonance. 27 The glucose response of the NBD-TR CCS ratiometric fluorescence measurements were fit to Equation (1), generating K apparent values of 6.2 and 1.7 mM for the C2 and C5 constructs, respectively ( Figure 5) . The solution K apparent of the NBD-TR C2 CCS GGBP upon glucose binding is essentially the same as for acrylodan-W183C GGBP (5.98 mM), 11 which, upon its immobilization in a hydrogel-based sensor, maintains responsiveness covering physiologically relevant glucose concentrations both in vitro 25 and in vivo. 26 Fluorescence resonance energy transfer is appealing for biosensor design because, unlike using single-dye intensity, ratiometric FRET emission measurements can be independent of biosensor concentration and can provide a reference function. Various strategies for combining PBPs with different FRET constructs have been described in the literature. Green fluorescent protein-variant PBPs produced as fusion proteins [31] [32] [33] [34] [35] have been used for in vivo detection of analytes such as maltose and glucose within living cells. A disadvantage of this strategy is that the fluorescent proteins are attached at the two termini of the PBP and the relative movement of the two termini relative to each upon ligand binding can be quite small for most PBPs.
Quantum dot FRET assays in which the quantum dot acts as the donor and an organic dye, such as a rhodamine or carbocyanine fluorophore, is the acceptor [36] [37] [38] have been successfully constructed; however, the reverse form of this assay design, with the quantum dot as the acceptor, has not provided adequate FRET signals. 39 This labeling strategy provides somewhat more flexibility, as the organic fluorophore may be attached through a cysteine anywhere on the PBP, although the quantum dot is attached through a polyhistidine complex at one terminus of the protein. A related strategy has been used to attach two fluorophores to proteins where one thiolreactive fluorophore is specifically attached through a cysteine and the other dye, typically an amine-reactive isothiocyanate derivative, is attached at the N-terminal amine. 40, 41 Although some fluorescence signal from these sensors was attributed to FRET, the intention of the second dye in these particular examples was primarily to provide a reference signal for the first dye, an environment-sensitive fluorophore. In a further example of dual labeling of GGBP, a first dye was introduced using transglutaminase at a glutamine near the N-terminus by an elegant delivery method employing GGBP with an engineered transglutaminase recognition site. 42 A second dye was attached selectively by cysteine conjugation. The authors concluded, however, that the resulting FRET constructs were not as sensitive as GGBP labeled with a single environment-sensitive dye, namely, Badan. This was due to the limited motion of the N-terminus label in the FRET construct relative to the protein domains upon glucose binding, which limited distance-dependent FRET to a 16% change.
In our examples, the donor, NBD, is environment sensitive, and the changes in fluorescence emission ratio upon glucose binding are more substantial. This results primarily from an increase in NBD fluorescence with a small decrease in energy transfer to the TR acceptor. Molecular modeling using conformational searches suggests the energy transfer decrease is likely due to a small distance increase between donor and acceptor as well as restricted orientation of the TR acceptor in the glucose-bound state.
The strategy we have presented here demonstrates an alternative method for constructing dual-labeled derivatives of PBPs, and potentially many other proteins, through ligand protection. In the case of PBPs, and GGBP in particular, this strategy provides greater flexibility for choosing protein sites for fluorophore conjugation for the development of robust FRET-based sensors in comparison with methods that rely on attachment of either one or both of the fluorophores at the protein termini. Notably, the use of an environment-sensitive donor fluorophore provides a much greater ratiometric fluorescence response than distance-dependent FRET.
